NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,998,000 | -42.6% | 120,461 | -19.8% | 0.01% | -48.1% |
| Q2 2020 | $3,479,000 | +51.7% | 150,250 | +16.9% | 0.03% | +17.4% |
| Q1 2020 | $2,294,000 | -32.7% | 128,517 | -18.7% | 0.02% | -11.5% |
| Q4 2019 | $3,410,000 | +2.9% | 158,000 | -13.1% | 0.03% | 0.0% |
| Q3 2019 | $3,314,000 | -34.7% | 181,922 | +27.5% | 0.03% | -36.6% |
| Q2 2019 | $5,075,000 | -1.4% | 142,636 | -6.8% | 0.04% | -2.4% |
| Q1 2019 | $5,145,000 | +8.5% | 153,122 | +6.1% | 0.04% | +5.0% |
| Q4 2018 | $4,742,000 | -43.3% | 144,268 | +5.1% | 0.04% | -27.3% |
| Q3 2018 | $8,369,000 | +27.2% | 137,285 | +1.9% | 0.06% | +25.0% |
| Q2 2018 | $6,579,000 | -90.2% | 134,748 | -78.6% | 0.04% | -73.0% |
| Q1 2018 | $66,875,000 | +641.3% | 629,361 | +316.6% | 0.16% | +676.2% |
| Q4 2017 | $9,021,000 | +90.3% | 151,055 | -23.5% | 0.02% | +90.9% |
| Q3 2017 | $4,740,000 | +2.4% | 197,540 | -16.6% | 0.01% | -8.3% |
| Q2 2017 | $4,630,000 | -18.2% | 236,830 | -1.8% | 0.01% | -20.0% |
| Q1 2017 | $5,657,000 | +74.0% | 241,110 | -9.0% | 0.02% | +66.7% |
| Q4 2016 | $3,252,000 | -38.9% | 265,043 | -14.4% | 0.01% | -47.1% |
| Q3 2016 | $5,319,000 | +5.4% | 309,610 | -12.7% | 0.02% | +6.2% |
| Q2 2016 | $5,047,000 | -3.1% | 354,666 | -6.4% | 0.02% | 0.0% |
| Q1 2016 | $5,209,000 | -56.0% | 378,810 | -46.1% | 0.02% | -52.9% |
| Q4 2015 | $11,840,000 | +31.9% | 702,643 | -14.2% | 0.03% | +21.4% |
| Q3 2015 | $8,977,000 | -4.7% | 819,147 | +8.8% | 0.03% | +21.7% |
| Q2 2015 | $9,423,000 | +104.8% | 753,230 | +80.1% | 0.02% | +109.1% |
| Q1 2015 | $4,600,000 | -2.5% | 418,200 | +37.5% | 0.01% | -8.3% |
| Q4 2014 | $4,716,000 | +45.0% | 304,245 | +12.9% | 0.01% | +50.0% |
| Q3 2014 | $3,252,000 | -7.6% | 269,387 | -1.8% | 0.01% | -11.1% |
| Q2 2014 | $3,518,000 | -10.8% | 274,389 | -15.7% | 0.01% | -18.2% |
| Q1 2014 | $3,943,000 | +12.7% | 325,320 | +5.5% | 0.01% | 0.0% |
| Q4 2013 | $3,500,000 | +14.0% | 308,382 | +4.9% | 0.01% | 0.0% |
| Q3 2013 | $3,071,000 | +3.6% | 293,849 | +14.5% | 0.01% | -8.3% |
| Q2 2013 | $2,964,000 | – | 256,637 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |